Ikarian Capital’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-32,689
Closed -$135K 213
2022
Q1
$135K Buy
32,689
+1,660
+5% +$5.56K 0.02% 176
2021
Q4
$79K Hold
31,029
0.01% 170
2021
Q3
$122K Sell
31,029
-137
-0.4% -$685 0.01% 205
2021
Q2
$201K Sell
31,166
-104,976
-77% -$724K 0.02% 207
2021
Q1
$1.1M Sell
136,142
-23,858
-15% -$219K 0.04% 236
2020
Q4
$1.34M Buy
+160,000
New +$1.08M 0.06% 170

Other funds holding GMDA

Ikarian Capital's GMDA Position: Q2 2022 in Review

Ikarian Capital sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2022, closing a stake of 32,689 shares — an estimated $135K sold.

Ikarian Capital first reported a position in GMDA in Q4 2020 and held it in 6 quarters. The position peaked at $1.34M in Q4 2020. 57 funds tracked by Wall St. Rank hold GMDA as of Q2 2022.

  • Ikarian Capital reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Ikarian Capital sold 32,689 Gamida Cell Ltd. Ordinary Shares shares in Q2 2022, an estimated $135K.
  • Ikarian Capital first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and held it in 6 quarters.
  • Ikarian Capital's Gamida Cell Ltd. Ordinary Shares position peaked at $1.34M in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.